These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36384529)
1. Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia. Bae KH; Lai F; Mong J; Niibori-Nambu A; Chan KH; Her Z; Osato M; Tan MH; Chen Q; Kurisawa M J Nanobiotechnology; 2022 Nov; 20(1):481. PubMed ID: 36384529 [TBL] [Abstract][Full Text] [Related]
2. Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia. Bae KH; Lai F; Oruc B; Osato M; Chen Q; Kurisawa M Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613821 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534 [TBL] [Abstract][Full Text] [Related]
5. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. Zhang W; Konopleva M; Shi YX; McQueen T; Harris D; Ling X; Estrov Z; Quintás-Cardama A; Small D; Cortes J; Andreeff M J Natl Cancer Inst; 2008 Feb; 100(3):184-98. PubMed ID: 18230792 [TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238 [TBL] [Abstract][Full Text] [Related]
7. A two-pronged anti-leukemic agent based on a hyaluronic acid-green tea catechin conjugate for inducing targeted cell death and terminal differentiation. Liang K; Bae KH; Nambu A; Dutta B; Chung JE; Osato M; Kurisawa M Biomater Sci; 2019 Dec; 8(1):497-505. PubMed ID: 31761907 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models. Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259 [TBL] [Abstract][Full Text] [Related]
9. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia. Wang A; Zhong H Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132 [TBL] [Abstract][Full Text] [Related]
10. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558 [No Abstract] [Full Text] [Related]
18. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638 [TBL] [Abstract][Full Text] [Related]
19. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. Zeng Z; Shi YX; Tsao T; Qiu Y; Kornblau SM; Baggerly KA; Liu W; Jessen K; Liu Y; Kantarjian H; Rommel C; Fruman DA; Andreeff M; Konopleva M Blood; 2012 Sep; 120(13):2679-89. PubMed ID: 22826565 [TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia. Lichtman EI; Du H; Shou P; Song F; Suzuki K; Ahn S; Li G; Ferrone S; Su L; Savoldo B; Dotti G Clin Cancer Res; 2021 Jun; 27(11):3141-3153. PubMed ID: 33531429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]